Fibrinopeptide A, human (TFA)

Fibrinopeptide A, human (TFA) Suppliers list
Company Name: Hunan Hui Bai Shi Biotechnology Co., Ltd.  
Tel: 0731-85526065 13308475853
Email: ivy@hnhbsj.com
Company Name: Hangzhou Peptidego Biotech Co.,Ltd.  
Tel: 0571-87213919 15967184799
Email: Eric@peptidego.com
Company Name: Zhejiang J&C Biological Technology Co.,Limited  
Tel: +1-2135480471
Email: sales@sarms4muscle.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Company Name: Guangzhou Weihua Biotechnology Co., Ltd  
Tel: 020-37239396 18922496242
Email: weihuasw@foxmail.com
Fibrinopeptide A, human (TFA) Basic information
Product Name:Fibrinopeptide A, human (TFA)
Synonyms:Fibrinopeptide A, human (TFA);Human fibrinopeptide A TFA
CAS:61533-47-9
MF:C65H98F3N19O28
MW:1650.6
EINECS:
Product Categories:
Mol File:61533-47-9.mol
Fibrinopeptide A, human (TFA) Structure
Fibrinopeptide A, human (TFA) Chemical Properties
form Solid
color White to off-white
SequenceH-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg-OH
Safety Information
MSDS Information
Fibrinopeptide A, human (TFA) Usage And Synthesis
UsesFibrinopeptide A, human TFA is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain[1].
in vivo

Fibrinopeptide A (FPA) is a small polypeptide cleaved from fibrinogen by thrombin, has a short half-life, and is considered a sensitive biochemical marker of thrombin activity, fibrin generation, and ongoing thrombosis[2].

References[1] Riedel T, et al. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood. 2011 Feb 3;117(5):1700-6. DOI:10.1182/blood-2010-08-300301
[2] Manolis AS, et al. Plasma level changes of fibrinopeptide A after uncomplicated coronary angioplasty. Clin Cardiol. 1993 Jul;16(7):548-52. DOI:10.1002/clc.4960160707
Fibrinopeptide A, human (TFA) Preparation Products And Raw materials
Tag:Fibrinopeptide A, human (TFA)(61533-47-9) Related Product Information
Human IgG1, kappa Isotype Control FORSYTHOSIDE A Zolbetuximab Tectorigenin Anti-Mouse Ly6G Antibody (1A8) RAT IGG2B, KAPPA